Enhancer ID: | E_02_0410 |
Species: | human |
Position : | chr7:129609040-129611040 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Obesity and type 2 diabetes |
Pubmed ID: | 30284014 |
Enhancer experiment: | RNA-Seq?ChIP-Seq?qPCR?TSS |
Enhancer experiment description: | Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed. |
Target gene : | NRF1 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed. |
TF name : | -- |
TF experiment: | RNA-Seq?ChIP-Seq?qPCR?TSS |
TF experiment description: | Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed. |
Enhancer function : | Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of ?-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|